Medical devices, healthcare technology and the business of care
510(k) clearance · K263065

MicroPort Total Knee System

Suzhou Microport Orthorecon Co., Ltd. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK263065

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-10-29 for K263065, the MicroPort Total Knee System, submitted by Suzhou Microport Orthorecon Co., Ltd. The filing was received 09/01/2026 as a Traditional 510(k), reviewed by the Orthopedic panel, and not reviewed by a third party. The device falls under product code JWH, with HRY listed as a subsequent product code, and regulation number 888.3560.

SESE in a 510(k) means the submission was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The source records do not identify the predicate device, the specific components or design changes at issue, or any clinical data, so the scope of what was cleared beyond the device name and classification remains unknown. No summary content was available in the retrieved excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263065
Regulatory pathway
510(k) premarket notification
Product code
JWH
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.

Product code
JWH
FDA device class
2

FDA decision timeline

  1. K263065 received

    Application receipt date recorded by FDA.

  2. K263065 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JWH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Suzhou Microport Orthorecon Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Suzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records